← Back to Knowledge Base

Primary topic: UGT2B15 gene steroid hormone processing

UGT2B15 Gene and Metabolism: What It Can Mean in a Pathway Report

UGT2B15 is tracked because it connects to estrogen-like hormone clearance, steroid bioavailability, and liver phase-I or phase-Ii context. The current evidence index links this gene to Estrogen metabolism with 1 SNP and 1 curated claim.

What is the UGT2B15 gene?

UGT2B15 glucuronidates androgen and steroid substrates; staged here as low-impact steroid glucuronidation context.

How UGT2B15 affects metabolism

When UGT2B15-related function is shifted, the practical effect is interpreted through estrogen-like hormone clearance, steroid bioavailability, and liver phase-I or phase-Ii context. This does not mean the pathway is active or impaired right now; it means the gene can help prioritize what to check next.

What happens when UGT2B15 is altered

Altered UGT2B15 signal should be treated as a DNA-based tendency, not a diagnosis. 1 claim currently passes the report-use gate. The useful question is whether symptoms, labs, and lifestyle context line up with the pathway signal.

Curated SNP evidence for UGT2B15

These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.

Evidence-backed report connection

UGT2B15 currently has 1 curated SNPs, 1 claim-level scores, and 1 claims eligible for pathway scoring.

Open the sample report
rs1902023UGT2B15 rs1902023 A/C orientation1 claims · 1 study rows

enzyme activity · C

androgen glucuronidation activity tendency

Moderate

rs1902023 C is associated with higher testosterone- and DHT-glucuronide formation in low-UGT2B17 human liver microsome context.

UGT2B15 rs1902023 C is staged as a context-dependent higher androgen glucuronidation activity allele in the source's A/C allele orientation.

Likely effectHigher enzyme activity signal
Signal sizeSmall signal
Evidence supportModerate support
Report useIncluded in pathway scoring
Show study evidence

Common symptoms people report

  • hormone-context questions that need lab confirmation
  • symptoms that vary with body composition, alcohol, medication, or liver context
  • unexpected SHBG, estradiol, or testosterone patterns

Biomarkers to validate

Estradiol, testosterone, and SHBG

Checks whether hormone balance is actually relevant.

ALT, AST, and GGT

Adds liver clearance context.

Medication and alcohol context

Helps separate genetics from stronger external drivers.

Where DNA analysis helps

DNA helps decide whether UGT2B15 deserves attention inside the broader Estrogen metabolism pathway. It is most useful when combined with biomarkers instead of used as a standalone answer.

Example interpretation

UGT2B15 may add context to estrogen-like hormone clearance, steroid bioavailability, and liver phase-I or phase-Ii context, especially when its SNP evidence lines up with other genes in the same pathway.

Suggested validation: Estradiol, testosterone, and SHBG.

What to do next

  • Review the Estrogen metabolism pathway result before interpreting UGT2B15 on its own.
  • Use relevant biomarkers to confirm whether this DNA tendency is visible in current biology.
  • Treat supplement or nutrition decisions as follow-up steps only after the pattern fits symptoms or labs.

Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.

Get My DNA Report

Related pages